CWM
CRL icon

CIBC World Markets’s Charles River Laboratories CRL Stock Holding History

CIBC World Markets’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.03M Buy
+5,139
New +$932K ﹤0.01% 730
2025
Q2 		$628K Buy
4,136
+295
+8% +$39.3K ﹤0.01% 784
2025
Q1 		$578K Sell
3,841
-4,245
-52% -$712K ﹤0.01% 934
2024
Q4 		$1.49M Buy
8,086
+1,124
+16% +$217K 0.01% 572
2024
Q3 		$1.37M Buy
6,962
+289
+4% +$60.1K 0.01% 580
2024
Q2 		$1.38M Buy
6,673
+1,560
+31% +$353K 0.01% 558
2024
Q1 		$1.39M Sell
5,113
-1,482
-22% -$354K 0.01% 590
2023
Q4 		$1.56M Buy
6,595
+3,765
+133% +$740K 0.01% 556
2023
Q3 		$555K Sell
2,830
-3,178
-53% -$652K 0.01% 558
2023
Q2 		$1.26M Buy
6,008
+3,435
+134% +$683K 0.01% 526
2023
Q1 		$519K Sell
2,573
-3,408
-57% -$772K 0.01% 582
2022
Q4 		$1.3M Buy
+5,981
New +$1.31M 0.01% 563
2022
Q3 		– Sell
-3,547
Closed -$759K – 572
2022
Q2 		$759K Sell
3,547
-6,837
-66% -$1.67M 0.01% 565
2022
Q1 		$2.95M Buy
10,384
+867
+9% +$267K 0.02% 347
2021
Q4 		$3.59M Sell
9,517
-1,855
-16% -$721K 0.02% 315
2021
Q3 		$4.69M Buy
11,372
+7,883
+226% +$3.27M 0.03% 296
2021
Q2 		$1.29M Sell
3,489
-1,855
-35% -$619K 0.01% 501
2021
Q1 		$1.55M Buy
+5,344
New +$1.49M 0.01% 504
2020
Q1 		– Sell
-24,900
Closed -$3.8M – 612
2019
Q4 		$3.8M Buy
+24,900
New +$3.45M 0.02% 454
2019
Q3 		– Sell
-132,500
Closed -$18.8M – 675
2019
Q2 		$18.8M Buy
132,500
+81,500
+160% +$11.1M 0.14% 158
2019
Q1 		$7.41M Hold
51,000
– – 0.06% 268
2018
Q4 		$5.77M Buy
51,000
+42,800
+522% +$5.36M 0.05% 279
2018
Q3 		$1.1M Buy
+8,200
New +$1.01M 0.01% 599

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

CIBC World Markets's CRL Position: Q4 2025 in Review

CIBC World Markets opened a new position in Charles River Laboratories (CRL) in Q4 2025: 5,139 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in CRL as recently as Q2 2025.

CIBC World Markets first reported a position in CRL in Q3 2018 and has held it in 23 quarters since. The position peaked at $18.8M in Q2 2019. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • CIBC World Markets held 5,139 shares of Charles River Laboratories worth $1.03M as of Q4 2025.
  • Charles River Laboratories was a new CIBC World Markets position in Q4 2025.
  • Charles River Laboratories made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #730 holding.
  • CIBC World Markets first reported a position in Charles River Laboratories in Q3 2018 and has held it in 23 quarters since.
  • CIBC World Markets's Charles River Laboratories position peaked at $18.8M in Q2 2019.
  • 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.